(Q35576159)

English

Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 1: growth factor and Ras signaling pathways

scientific article published on October 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1 reference

Europe PubMed Central

Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 1: Growth factor and Ras signaling pathways (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 1: growth factor and Ras signaling pathways (English)

1 reference

10.1586/14737140.3.5.595

https://api.crossref.org/works/10.1586/14737140.3.5.595

28 March 2024

1 reference

10.1586/14737140.3.5.595

https://api.crossref.org/works/10.1586/14737140.3.5.595

28 March 2024

author name string

Herbert B. Newton

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14599084

28 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14599084

28 March 2024

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

full work available at URL

http://www.tandfonline.com/doi/pdf/10.1586/14737140.3.5.595

1 reference

10.1586/14737140.3.5.595

https://api.crossref.org/works/10.1586/14737140.3.5.595

28 March 2024

Expert Review of Anticancer Therapy

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

595-614

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Current epidemiological trends and surveillance issues in brain tumors

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Clinical presentation, diagnosis, and pharmacotherapy of patients with primary brain tumors

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Chemotherapy for the treatment of metastatic brain tumors

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Tumor suppressor genes and cancer of the human nervous system

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Malignant glioma: genetics and biology of a grave matter.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Growth factors and cancer

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

PDGF-D, a new protease-activated growth factor

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Protein tyrosine kinase structure and function

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Monoclonal antibodies in the treatment of malignancy: basic concepts and recent developments

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Epidermal Growth Factor

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Tyrosine kinase inhibition: an approach to drug development

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Platelet-derived growth factor receptors: a therapeutic target in solid tumors

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Small molecule inhibitors of the platelet-derived growth factor receptor, the fibroblast growth factor receptor, and Src family tyrosine kinases

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Imatinib mesylate--a new oral targeted therapy

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

The epidermal growth factor receptor and its inhibition in cancer therapy

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Epidermal growth factor receptor in human glioma.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Proliferation and motility responses of primary and recurrent gliomas related to changes in epidermal growth factor receptor expression.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

EGFR overexpression and radiation response in glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Developing inhibitors of the epidermal growth factor receptor for cancer treatment.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Transforming growth factor-alpha, epidermal growth factor receptor, and proliferating potential in benign and malignant gliomas

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

TGF-beta signal transduction

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

The role of transforming growth factor beta in glioma progression

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Transforming growth factor beta as a potential tumor progression factor among hyperdiploid glioblastoma cultures: evidence for the role of platelet-derived growth factor.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

The fibroblast growth factor family: structural and biological properties

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Role of the insulin-like growth factor family in cancer development and progression

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Insulin and insulin-like growth factor I in brain tumors: binding and in vitro effects.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Insulin-like growth factor-I receptors in human glial tumors

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Activation of the IGF-IR system contributes to malignant growth of human and mouse medulloblastomas.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Proteins regulating Ras and its relatives

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Function and regulation of ras.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Blocking oncogenic Ras signaling for cancer therapy

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Proliferation of human malignant astrocytomas is dependent on Ras activation.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

ras-p21-induced cell transformation: unique signal transduction pathways and implications for the design of new chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Farnesyltransferase and geranylgeranyltransferase I inhibitors in cancer therapy: important mechanistic and bench to bedside issues

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Farnesyl transferase inhibitors: a novel targeted tnerapy for cancer

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Inhibition of Ras and related guanosine triphosphate-dependent proteins as a therapeutic strategy for blocking malignant glioma growth: II--preclinical studies in a nude mouse model.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Discovering novel chemotherapeutic drugs for the third millennium

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

The impact of genomic and proteomic technologies on the development of new cancer drugs

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Microarrays as cancer keys: an array of possibilities.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.3.5.595

21 January 2018

Localization of acidic and basic fibroblast growth factor mRNA in human brain tumors.

61

1 reference

10.1586/14737140.3.5.595

https://api.crossref.org/works/10.1586/14737140.3.5.595

28 March 2024

Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors

71

1 reference

10.1586/14737140.3.5.595

https://api.crossref.org/works/10.1586/14737140.3.5.595

28 March 2024

DNA microarrays in clinical oncology

106

1 reference

10.1586/14737140.3.5.595

https://api.crossref.org/works/10.1586/14737140.3.5.595

28 March 2024

Identifiers

10.1586/14737140.3.5.595

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35576159&oldid=2113297598"